These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2965871)

  • 1. Degradation of [125I]-atrial natriuretic peptide by a soluble metallopeptidase isolated from rat ventricular myocytes.
    Rugg EL; Aiton JF; Cramb G
    Biochem Biophys Res Commun; 1988 Apr; 152(1):294-300. PubMed ID: 2965871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of atrial natriuretic peptide degradation by cell-surface peptidase activity on endothelial cells.
    Frost SJ; Whitson PA
    J Cell Biochem; 1993 Jun; 52(2):227-36. PubMed ID: 8366138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide binds to ANP-R1 receptors in neuroblastoma cells or is degraded extracellularly at the Ser-Phe bond.
    Delporte C; Poloczek P; Tastenoy M; Winand J; Christophe J
    Eur J Pharmacol; 1992 Nov; 227(3):247-56. PubMed ID: 1335413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respective roles of kallikrein and endopeptidase 24.11 in the metabolic pathway of atrial natriuretic peptide in the rat.
    Vanneste Y; Pauwels S; Lambotte L; Michel A; Dimaline R; Deschodt-Lanckman M
    Biochem J; 1990 Aug; 269(3):801-6. PubMed ID: 1697165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A liver metalloendopeptidase which degrades the circulating hypotensive peptide hormones bradykinin and atrial natriuretic peptide.
    Carvalho KM; Nava RA; França MS; Medeiros MA; Camarão GC; Juliano L
    Braz J Med Biol Res; 1999 Jan; 32(1):51-4. PubMed ID: 10347768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of binding sites for [125I] ANP in the myocardium but not in Purkinje fibers of the bovine heart.
    Hansson M; Barroso C; Gulbenkian S; Forsgren S
    Cell Tissue Res; 1997 Dec; 290(3):669-73. PubMed ID: 9369543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney.
    Janas J; Sitkiewicz D; Warnawin K; Janas RM
    J Hypertens; 1994 Oct; 12(10):1155-62. PubMed ID: 7836731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.
    Kinnunen P; Taskinen T; Järvinen M; Ruskoaho H
    Br J Pharmacol; 1991 Feb; 102(2):453-61. PubMed ID: 1826618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide degradation by CPA47 cells: evidence for a divalent cation-independent cell-surface proteolytic activity.
    Frost SJ; Chen YM; Whitson PA
    Biochim Biophys Acta; 1992 Nov; 1112(1):45-51. PubMed ID: 1420268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
    Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1628-35. PubMed ID: 1838029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
    Kinnunen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1993 May; 132(5):1961-70. PubMed ID: 8477647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and inhibition of neutral metalloendopeptidase (NEP) (EC 3.4.24.11), the major degradative enzyme for atrial natriuretic peptide, in the rat kidney.
    Kanazawa M; Johnston CI
    Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):449-53. PubMed ID: 1833101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial characterization of a metalloendopeptidase activity produced by cultured endothelial cells that removes the COOH-terminal tripeptide from 125I-atrial natriuretic factor.
    Johnson GR; Foster CJ
    Biochem Biophys Res Commun; 1990 Feb; 167(1):110-6. PubMed ID: 2138018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.
    Sonnenberg JL; Sakane Y; Jeng AY; Koehn JA; Ansell JA; Wennogle LP; Ghai RD
    Peptides; 1988; 9(1):173-80. PubMed ID: 2966343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.
    Kinnunen P; Taskinen T; Leppäluoto J; Ruskoaho H
    Br J Pharmacol; 1990 Apr; 99(4):701-8. PubMed ID: 2141796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
    Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide and its messenger ribonucleic acid in overloaded and overload-released ventricles of rat.
    Gu J; D'Andrea M; Seethapathy M
    Endocrinology; 1989 Oct; 125(4):2066-74. PubMed ID: 2529116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conversion of atrial natriuretic peptide (ANP)-(1-126) to ANP-(99-126) by rat serum: contribution to ANP cleavage in isolated perfused rat hearts.
    Gibson TR; Shields PP; Glembotski CC
    Endocrinology; 1987 Feb; 120(2):764-72. PubMed ID: 2948815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide in plasma, atria, ventricles, and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats.
    Ruskoaho H; Taskinen T; Pesonen A; Vuolteenaho O; Leppäluoto J; Tuomisto L
    Endocrinology; 1989 May; 124(5):2595-603. PubMed ID: 2523304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.